Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Guba

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Transplantation Research|February 12, 2014
Center volume, competition, and outcome in German liver transplant centersMarkus Guba
Chirurgie (Heidelberg, Germany)|February 8, 2024
[Liver transplantation for treatment of nonresectable primary and secondary liver malignancies : Hepatocellular and cholangiocellular carcinomas and colorectal liver metastases]Markus Guba, Jens Werner
Zentralblatt Fur Chirurgie|July 25, 2017
[Perception of the Liver Allocation System by Different Stakeholders]Christine Englschalk, Markus Guba
MMW Fortschritte Der Medizin|May 29, 2015
[Safety of brain dead organ donors]Markus Guba, Jens Werner
The New England Journal of Medicine|June 6, 2008
Reduced exposure to calcineurin inhibitors in renal transplantationMarkus Guba, Karl-Walter Jauch
MMW Fortschritte Der Medizin|October 17, 2014
[Chances and risks of live donor liver transplantation]Joachim Andrassy, Jens Werner, Markus Guba
Studies in Health Technology and Informatics|May 23, 2026
From Excel to Automation: The Transplant Mapper for Interoperable Transplant Data ManagementMarcel Müller, Kurt Kruber, Ulrich Mansmann, et al.
MMW Fortschritte Der Medizin|August 21, 2015
[Multimodal treatment of colorectal liver metastases]Markus Albertsmeier, Sebastian Stintzing, Markus Guba, et al.
Journal of Surgical Oncology|July 30, 2004
Vascular endothelial growth factor in esophageal cancerAxel Kleespies, Markus Guba, Karl-Walter Jauch, et al.
Transplantation|June 30, 2004
Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantationMarkus Guba, Christian Graeb, Karl-Walter Jauch, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Transplantation Research|February 12, 2014
Center volume, competition, and outcome in German liver transplant centersMarkus Guba
Chirurgie (Heidelberg, Germany)|February 8, 2024
[Liver transplantation for treatment of nonresectable primary and secondary liver malignancies : Hepatocellular and cholangiocellular carcinomas and colorectal liver metastases]Markus Guba, Jens Werner
Zentralblatt Fur Chirurgie|July 25, 2017
[Perception of the Liver Allocation System by Different Stakeholders]Christine Englschalk, Markus Guba
MMW Fortschritte Der Medizin|May 29, 2015
[Safety of brain dead organ donors]Markus Guba, Jens Werner
The New England Journal of Medicine|June 6, 2008
Reduced exposure to calcineurin inhibitors in renal transplantationMarkus Guba, Karl-Walter Jauch
MMW Fortschritte Der Medizin|October 17, 2014
[Chances and risks of live donor liver transplantation]Joachim Andrassy, Jens Werner, Markus Guba
Studies in Health Technology and Informatics|May 23, 2026
From Excel to Automation: The Transplant Mapper for Interoperable Transplant Data ManagementMarcel Müller, Kurt Kruber, Ulrich Mansmann, et al.
MMW Fortschritte Der Medizin|August 21, 2015
[Multimodal treatment of colorectal liver metastases]Markus Albertsmeier, Sebastian Stintzing, Markus Guba, et al.
Journal of Surgical Oncology|July 30, 2004
Vascular endothelial growth factor in esophageal cancerAxel Kleespies, Markus Guba, Karl-Walter Jauch, et al.
Transplantation|June 30, 2004
Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantationMarkus Guba, Christian Graeb, Karl-Walter Jauch, et al.
Pageof 15